Exponent, Inc. (NASDAQ:EXPO - Get Free Report) CEO Catherine Corrigan sold 4,905 shares of the business's stock in a transaction on Monday, September 15th. The stock was sold at an average price of $69.91, for a total value of $342,908.55. Following the completion of the transaction, the chief executive officer directly owned 82,753 shares in the company, valued at approximately $5,785,262.23. This represents a 5.60% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Catherine Corrigan also recently made the following trade(s):
- On Thursday, August 14th, Catherine Corrigan sold 4,896 shares of Exponent stock. The shares were sold at an average price of $71.09, for a total value of $348,056.64.
Exponent Stock Performance
EXPO traded up $0.20 during midday trading on Tuesday, reaching $69.67. 463,957 shares of the company were exchanged, compared to its average volume of 471,178. Exponent, Inc. has a one year low of $63.81 and a one year high of $115.75. The stock has a market capitalization of $3.52 billion, a P/E ratio of 34.84 and a beta of 0.94. The stock's 50-day simple moving average is $71.37 and its 200 day simple moving average is $76.00.
Exponent (NASDAQ:EXPO - Get Free Report) last issued its earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The firm had revenue of $132.87 million for the quarter, compared to analysts' expectations of $130.82 million. During the same quarter last year, the business earned $0.57 earnings per share. The company's revenue was up 7.3% compared to the same quarter last year. On average, research analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current year.
Exponent Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 19th. Stockholders of record on Friday, September 5th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Friday, September 5th. Exponent's payout ratio is 60.00%.
Institutional Investors Weigh In On Exponent
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Kayne Anderson Rudnick Investment Management LLC increased its holdings in shares of Exponent by 1.2% during the 1st quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,791,747 shares of the business services provider's stock worth $388,419,000 after acquiring an additional 55,190 shares during the last quarter. Geneva Capital Management LLC increased its holdings in shares of Exponent by 7.6% during the 2nd quarter. Geneva Capital Management LLC now owns 1,877,765 shares of the business services provider's stock worth $140,288,000 after acquiring an additional 131,937 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Exponent by 1.3% during the 2nd quarter. Geode Capital Management LLC now owns 1,597,542 shares of the business services provider's stock worth $119,360,000 after acquiring an additional 21,272 shares during the last quarter. Bank of America Corp DE increased its holdings in shares of Exponent by 15.9% during the 2nd quarter. Bank of America Corp DE now owns 645,726 shares of the business services provider's stock worth $48,242,000 after acquiring an additional 88,350 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in shares of Exponent by 25.1% during the 2nd quarter. JPMorgan Chase & Co. now owns 638,081 shares of the business services provider's stock worth $47,671,000 after acquiring an additional 128,131 shares during the last quarter. Institutional investors and hedge funds own 92.37% of the company's stock.
About Exponent
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.